Cytophage Announces Fiscal Year End 2023 Results

Winnipeg, April 30, 2024. Cytophage Technologies Ltd. (TSXV:CYTO) (“Cytophage” or the “Company”), the only publicly traded phage company that is focused on bacteriophage solutions for both animal health and human health, today released its fiscal year end results for the year ending December 31st, 2023.

We can win the war against battlefield infection.
Cytophage was selected for the Defense Innovation Award 2019.

Winner of 2018 Nutreco Feed Tech Challenge
For our breakthrough innovation to help feed the world.

Swine Bacteriophage

We’re helping farmers meet the need and the demand for a healthier food chain.

Funded in part by the Canada and Manitoba governments through the Canadian Agricultural Partnership – Ag Action Manitoba Program. Learn more

Contact Us

Learn more about our bacteriophage solutions.

Cytophage Technologies Ltd. © 2019